UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma

Nature communications, 2023-03, Vol.14 (1), p.1610-1610, Article 1610

2023

Volltextzugriff (PDF)

Functional single-cell hybridoma screening using droplet-based microfluidics

Proceedings of the National Academy of Sciences - PNAS, 2012-07, Vol.109 (29), p.11570-11575

2012

Volltextzugriff (PDF)

Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression

Proceedings of the National Academy of Sciences - PNAS, 2017-07, Vol.114 (30), p.E6147-E6156

2017

Volltextzugriff (PDF)

Mesenchymal Stem Cells Successfully Deliver Oncolytic Virotherapy to Diffuse Intrinsic Pontine Glioma

Clinical cancer research, 2021-03, Vol.27 (6), p.1766-1777

2021

Volltextzugriff (PDF)

Myeloid-Derived Suppressive Cells Promote B cell-Mediated Immunosuppression via Transfer of PD-L1 in Glioblastoma

Cancer immunology research, 2019-12, Vol.7 (12), p.1928-1943

2019

Volltextzugriff (PDF)

Intranasal delivery of stem cell-based therapies for the treatment of brain malignancies

Expert opinion on drug delivery, 2018-02, Vol.15 (2), p.163-172

2018

Volltextzugriff (PDF)

IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM

Journal for immunotherapy of cancer, 2023-02, Vol.11 (2), p.e006239

2023

Volltextzugriff (PDF)

In vitro vascular differentiation system efficiently produces natural killer cells for cancer immunotherapies

Oncoimmunology, 2023-12, Vol.12 (1), p.2240670

2023

Volltextzugriff (PDF)

Schnurri-3 drives tumor growth and invasion in cancer cells expressing interleukin-13 receptor alpha 2

Cell death & disease, 2023-11, Vol.14 (11), p.742-13, Article 742

2023

Volltextzugriff (PDF)

X-ray Activated Nanoplatforms for Deep Tissue Photodynamic Therapy

Nanomaterials (Basel, Switzerland), 2023-02, Vol.13 (4), p.673

2023

Volltextzugriff (PDF)

Mesenchymal stem cells modified with a single-chain antibody against EGFRvIII successfully inhibit the growth of human xenograft malignant glioma

PloS one, 2010-03, Vol.5 (3), p.e9750-e9750

2010

Volltextzugriff (PDF)

Bi-Specific Killer Cell Engager Enhances NK Cell Activity against Interleukin-13 Receptor Alpha-2 Positive Gliomas

Cells (Basel, Switzerland), 2023-06, Vol.12 (13), p.1716

2023

Volltextzugriff (PDF)

Pharmacologic modulation of nasal epithelium augments neural stem cell targeting of glioblastoma

Theranostics, 2019-01, Vol.9 (7), p.2071-2083

2019

Volltextzugriff (PDF)

Intranasal Oncolytic Virotherapy with CXCR4-Enhanced Stem Cells Extends Survival in Mouse Model of Glioma

Stem cell reports, 2016-09, Vol.7 (3), p.471-482

2016

Volltextzugriff (PDF)

Neural Stem Cells Secreting Anti‐HER2 Antibody Improve Survival in a Preclinical Model of HER2 Overexpressing Breast Cancer Brain Metastases

Stem cells (Dayton, Ohio), 2015-10, Vol.33 (10), p.2985-2994

2015

Volltextzugriff (PDF)

A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with Verteporfin

Cancers, 2023-02, Vol.15 (4), p.1085

2023

Volltextzugriff (PDF)

Characterization and Immunotherapeutic Implications for a Novel Antibody Targeting Interleukin (IL)-13 Receptor α2

The Journal of biological chemistry, 2012-08, Vol.287 (36), p.30215-30227

2012

Volltextzugriff (PDF)

Liposomal Extravasation and Accumulation in Tumors as Studied by Fluorescence Microscopy and Imaging Depend on the Fluorescent Label

ACS nano, 2021-07, Vol.15 (7), p.11880-11890

2021

Volltextzugriff (PDF)

Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Rα2-CAR T Cells but Results in Antigen Loss Variants

Cancer immunology research, 2017-07, Vol.5 (7), p.571-581

2017

Volltextzugriff (PDF)

Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors

Clinical cancer research, 2014-10, Vol.20 (20), p.5290-5301

2014

Volltextzugriff (PDF)

New Approaches to Glioblastoma

Annual review of medicine, 2022-01, Vol.73 (1), p.279-292

2022

Volltextzugriff (PDF)

Therapeutic targeting of tumor-associated myeloid cells synergizes with radiation therapy for glioblastoma

Proceedings of the National Academy of Sciences - PNAS, 2019-11, Vol.116 (47), p.23714-23723

2019

Volltextzugriff (PDF)

IDO Expression in Brain Tumors Increases the Recruitment of Regulatory T Cells and Negatively Impacts Survival

Clinical cancer research, 2012-11, Vol.18 (22), p.6110-6121

2012

Volltextzugriff (PDF)

IL13 Receptor α2 Signaling Requires a Scaffold Protein, FAM120A, to Activate the FAK and PI3K Pathways in Colon Cancer Metastasis

Cancer research (Chicago, Ill.), 2015-06, Vol.75 (12), p.2434-2444

2015

Volltextzugriff (PDF)

1 – 25 von 117

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(113)
Mit Volltextzugriff
(109)

Publikationsform

Artikel
(117)

Sprache

Englisch
(117)

Erscheinungsjahr

n.n

Thema

Science & Technology
(76)
Life Sciences & Biomedicine
(62)
Humans
(52)
Animals
(51)
Mice
(33)
Brain Cancer
(25)
Glioblastoma
(21)
Immunotherapy
(20)
Male
(20)
Oncology
(19)
Tumors
(19)
Cell Line, Tumor
(18)
Glioma
(18)
Xenograft Model Antitumor Assays
(14)
Brain Neoplasms - Therapy
(13)
Brain Tumors
(13)
Cho Cells
(13)
Cricetinae
(13)
Science & Technology - Other Topics
(13)
Antibodies
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma

Functional single-cell hybridoma screening using droplet-based microfluidics

Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression

Mesenchymal Stem Cells Successfully Deliver Oncolytic Virotherapy to Diffuse Intrinsic Pontine Glioma

Myeloid-Derived Suppressive Cells Promote B cell-Mediated Immunosuppression via Transfer of PD-L1 in Glioblastoma

Intranasal delivery of stem cell-based therapies for the treatment of brain malignancies

IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM

In vitro vascular differentiation system efficiently produces natural killer cells for cancer immunotherapies

Schnurri-3 drives tumor growth and invasion in cancer cells expressing interleukin-13 receptor alpha 2

X-ray Activated Nanoplatforms for Deep Tissue Photodynamic Therapy

Mesenchymal stem cells modified with a single-chain antibody against EGFRvIII successfully inhibit the growth of human xenograft malignant glioma

Bi-Specific Killer Cell Engager Enhances NK Cell Activity against Interleukin-13 Receptor Alpha-2 Positive Gliomas

Pharmacologic modulation of nasal epithelium augments neural stem cell targeting of glioblastoma

Intranasal Oncolytic Virotherapy with CXCR4-Enhanced Stem Cells Extends Survival in Mouse Model of Glioma

Neural Stem Cells Secreting Anti‐HER2 Antibody Improve Survival in a Preclinical Model of HER2 Overexpressing Breast Cancer Brain Metastases

A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with Verteporfin

Characterization and Immunotherapeutic Implications for a Novel Antibody Targeting Interleukin (IL)-13 Receptor α2

Liposomal Extravasation and Accumulation in Tumors as Studied by Fluorescence Microscopy and Imaging Depend on the Fluorescent Label

Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Rα2-CAR T Cells but Results in Antigen Loss Variants

Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors

New Approaches to Glioblastoma

Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial

Therapeutic targeting of tumor-associated myeloid cells synergizes with radiation therapy for glioblastoma

IDO Expression in Brain Tumors Increases the Recruitment of Regulatory T Cells and Negatively Impacts Survival

IL13 Receptor α2 Signaling Requires a Scaffold Protein, FAM120A, to Activate the FAK and PI3K Pathways in Colon Cancer Metastasis

Aktive Filter

Suchergebnisse filtern